Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The main component of intravenous human immunoglobulin (pH4) is human immunoglobulin, which is made of healthy human plasma, separated and purified by low-temperature ethanol protein separation method, removes anti-complement activity and is made by double virus inactivation treatment, containing the appropriate amount of glucose or maltose As a stabilizer (see specifications), it does not contain preservatives and antibiotics.
This report elaborates on the current development of the Human Immunnglnhlobulin (pH4) for Intravenous Injection industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
CTBB
Boya-Bio
Shanghai RAAS
Weiguang Biological
Guangdong Shuagnlin Bio-pharmacy
Hualan Bio
Nanyue Biopharming
Beijing Tiantan Biological Products
By Type:
10g/200ml
1g/20ml
25g/50ml
125g/25ml
5g/100ml
By Application:
Others
Hospital
Clinic
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Overview 2018-2029
-
1.1 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Industry Development Overview
-
1.2 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Industry Development History
-
1.3 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Industry Market Size (2018-2029)
-
1.4 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Analysis by Type from Production Side
-
1.4.1 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume, Production Value and Growth Rate of 10g/200ml (2018-2029)
-
1.4.2 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume, Production Value and Growth Rate of 1g/20ml (2018-2029)
-
1.4.3 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume, Production Value and Growth Rate of 25g/50ml (2018-2029)
-
1.4.4 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume, Production Value and Growth Rate of 125g/25ml (2018-2029)
-
1.4.5 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume, Production Value and Growth Rate of 5g/100ml (2018-2029)
-
1.5 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Analysis by Application from Consumption End
-
1.5.1 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.2 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.5.3 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
1.6 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Analysis by Region
-
1.6.1 North China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate from 2018-2029
Chapter 2 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Status and Competition at home and abroad in 2023
-
2.2.2 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Status and Competition Analysis in 2023
-
2.2.3 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Human Immunnglnhlobulin (pH4) for Intravenous Injection Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Human Immunnglnhlobulin (pH4) for Intravenous Injection Industry Development
Chapter 3 Human Immunnglnhlobulin (pH4) for Intravenous InjectionIndustry Chain Analysis
-
3.1 Human Immunnglnhlobulin (pH4) for Intravenous Injection Industry Chain
-
3.2 Human Immunnglnhlobulin (pH4) for Intravenous Injection Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Human Immunnglnhlobulin (pH4) for Intravenous Injection Market
-
3.3 Human Immunnglnhlobulin (pH4) for Intravenous Injection Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Human Immunnglnhlobulin (pH4) for Intravenous Injection Market
Chapter 4 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market, by Type
-
4.1 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Total Production Volume and Growth Rate from Production Side
-
4.5 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume and Growth Rate, by Type
-
4.5.1 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume and Growth Rate of 10g/200ml
-
4.5.2 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume and Growth Rate of 1g/20ml
-
4.5.3 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume and Growth Rate of 25g/50ml
-
4.5.4 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume and Growth Rate of 125g/25ml
-
4.5.5 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume and Growth Rate of 5g/100ml
Chapter 5 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Total Market Size and Growth Rate from Consumption End
-
5.5 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate, by Application
-
5.5.1 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate of Others
-
5.5.2 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate of Hospital
-
5.5.3 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate of Clinic
Chapter 6 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market, by Region
-
6.1 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume and Production Value, by Region
-
6.2 China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume and Sales Value, by Region
Chapter 7 North China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Analysis
-
7.1 North China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market, by Type
-
7.2 North China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market, by Application
Chapter 8 Central China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Analysis
-
8.1 Central China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market, by Type
-
8.2 Central China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market, by Application
Chapter 9 South China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Analysis
-
9.1 South China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market, by Type
-
9.2 South China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market, by Application
Chapter 10 East China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Analysis
-
10.1 East China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market, by Type
-
10.2 East China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market, by Application
Chapter 11 Northeast China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Analysis
-
11.1 Northeast China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market, by Type
-
11.2 Northeast China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market, by Application
Chapter 12 Southwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Analysis
-
12.1 Southwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market, by Type
-
12.2 Southwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market, by Application
Chapter 13 Northwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Analysis
-
13.1 Northwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market, by Type
-
13.2 Northwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market, by Application
Chapter 14 Company Profiles
-
14.1 CTBB
-
14.1.1 CTBB Company Profile
-
14.1.2 CTBB Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Boya-Bio
-
14.2.1 Boya-Bio Company Profile
-
14.2.2 Boya-Bio Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Shanghai RAAS
-
14.3.1 Shanghai RAAS Company Profile
-
14.3.2 Shanghai RAAS Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Weiguang Biological
-
14.4.1 Weiguang Biological Company Profile
-
14.4.2 Weiguang Biological Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Guangdong Shuagnlin Bio-pharmacy
-
14.5.1 Guangdong Shuagnlin Bio-pharmacy Company Profile
-
14.5.2 Guangdong Shuagnlin Bio-pharmacy Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Hualan Bio
-
14.6.1 Hualan Bio Company Profile
-
14.6.2 Hualan Bio Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Nanyue Biopharming
-
14.7.1 Nanyue Biopharming Company Profile
-
14.7.2 Nanyue Biopharming Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Beijing Tiantan Biological Products
-
14.8.1 Beijing Tiantan Biological Products Company Profile
-
14.8.2 Beijing Tiantan Biological Products Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Performance
-
14.8.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Human Immunnglnhlobulin (pH4) for Intravenous Injection Industry Research Conclusions
-
15.2 Human Immunnglnhlobulin (pH4) for Intravenous Injection Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Industry Market Size (2018-2029)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume, Production Value and Growth Rate of 10g/200ml (2018-2029)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume, Production Value and Growth Rate of 1g/20ml (2018-2029)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume, Production Value and Growth Rate of 25g/50ml (2018-2029)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume, Production Value and Growth Rate of 125g/25ml (2018-2029)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume, Production Value and Growth Rate of 5g/100ml (2018-2029)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
Figure North China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate from 2018-2029
-
Figure Central China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate from 2018-2029
-
Figure South China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate from 2018-2029
-
Figure East China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate from 2018-2029
-
Figure Human Immunnglnhlobulin (pH4) for Intravenous Injection Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Share by Type in 2018
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Share by Type in 2023
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume and Growth Rate of 10g/200ml (2018-2023)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume and Growth Rate of 1g/20ml (2018-2023)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume and Growth Rate of 25g/50ml (2018-2023)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume and Growth Rate of 125g/25ml (2018-2023)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume and Growth Rate of 5g/100ml (2018-2023)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Share by Application in 2018
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Share by Application in 2023
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Total Market Size and Growth Rate from Consumption End
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate of Others (2018-2023)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate of Hospital (2018-2023)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Market Size and Growth Rate of Clinic (2018-2023)
-
Table China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume by Region (2018-2023)
-
Table China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume Share by Region (2018-2023)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume Share by Region (2018-2023)
-
Table China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Value by Region (2018-2023)
-
Table China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Value Share by Region (2018-2023)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Value Share by Region (2018-2023)
-
Table China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume by Region (2018-2023)
-
Table China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume Share by Region (2018-2023)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume Share by Region (2018-2023)
-
Table China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Value by Region (2018-2023)
-
Table China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Value Share by Region (2018-2023)
-
Figure China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Value Share by Region (2018-2023)
-
Table North China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume by Type (2018-2023)
-
Table North China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume Share by Type (2018-2023)
-
Figure North China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume Share by Type (2018-2023)
-
Table North China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume by Application (2018-2023)
-
Table North China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Figure North China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Table Central China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume by Type (2018-2023)
-
Table Central China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume Share by Type (2018-2023)
-
Figure Central China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume Share by Type (2018-2023)
-
Table Central China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume by Application (2018-2023)
-
Table Central China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Figure Central China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Table South China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume by Type (2018-2023)
-
Table South China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume Share by Type (2018-2023)
-
Figure South China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume Share by Type (2018-2023)
-
Table South China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume by Application (2018-2023)
-
Table South China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Figure South China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Table East China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume by Type (2018-2023)
-
Table East China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume Share by Type (2018-2023)
-
Figure East China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume Share by Type (2018-2023)
-
Table East China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume by Application (2018-2023)
-
Table East China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Figure East China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Table Northeast China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume by Type (2018-2023)
-
Table Northeast China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume Share by Type (2018-2023)
-
Figure Northeast China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume Share by Type (2018-2023)
-
Table Northeast China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume by Application (2018-2023)
-
Table Northeast China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Table Southwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume by Type (2018-2023)
-
Table Southwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume Share by Type (2018-2023)
-
Figure Southwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume Share by Type (2018-2023)
-
Table Southwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume by Application (2018-2023)
-
Table Southwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Table Northwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume by Type (2018-2023)
-
Table Northwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume Share by Type (2018-2023)
-
Figure Northwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Production Volume Share by Type (2018-2023)
-
Table Northwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume by Application (2018-2023)
-
Table Northwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Human Immunnglnhlobulin (pH4) for Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Table CTBB Company Profile
-
Table CTBB Human Immunnglnhlobulin (pH4) for Intravenous Injection Revenue, Price and Gross (2018-2023)
-
Table Boya-Bio Company Profile
-
Table Boya-Bio Human Immunnglnhlobulin (pH4) for Intravenous Injection Revenue, Price and Gross (2018-2023)
-
Table Shanghai RAAS Company Profile
-
Table Shanghai RAAS Human Immunnglnhlobulin (pH4) for Intravenous Injection Revenue, Price and Gross (2018-2023)
-
Table Weiguang Biological Company Profile
-
Table Weiguang Biological Human Immunnglnhlobulin (pH4) for Intravenous Injection Revenue, Price and Gross (2018-2023)
-
Table Guangdong Shuagnlin Bio-pharmacy Company Profile
-
Table Guangdong Shuagnlin Bio-pharmacy Human Immunnglnhlobulin (pH4) for Intravenous Injection Revenue, Price and Gross (2018-2023)
-
Table Hualan Bio Company Profile
-
Table Hualan Bio Human Immunnglnhlobulin (pH4) for Intravenous Injection Revenue, Price and Gross (2018-2023)
-
Table Nanyue Biopharming Company Profile
-
Table Nanyue Biopharming Human Immunnglnhlobulin (pH4) for Intravenous Injection Revenue, Price and Gross (2018-2023)
-
Table Beijing Tiantan Biological Products Company Profile
-
Table Beijing Tiantan Biological Products Human Immunnglnhlobulin (pH4) for Intravenous Injection Revenue, Price and Gross (2018-2023)
-
